|
Health Conditions
|
Gastroesophageal Reflux Disease (GERD)
What is on the horizon?
GERD may often be missed in children. The FDA has approved omeprazole (Prilosec) for children aged one year and older. Esomeprazole (Nexium) was also recently approved for children aged one to eleven years. Currently, a study is being performed to assess the efficacy of another PPI, pantoprazole (Protonix), to treat GERD in children. Another study is looking at the safety of nizatidine (Axid), an H2 blocker, in infants.
Baclofen, a muscle relaxant and a pro-motility drug similar to Reglan, is being studied in patients with slow gastric emptying. This medication may be another option for patients with GERD when therapy with H2 blockers or PPIs does not work.
As of May 2006, research suggests that patients who failed surgery for severe GERD can opt for another surgery. The study showed that reoperation for failed anti-reflux surgery is safe and effective.
|
Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.
|
|
What is on the horizon?
